High Tower Advisors, LLC Ocugen, Inc. Transaction History

High Tower Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$0.36 - $0.57 $3 - $6	11 Added 0.11%	10,311 $5,000
Q1 2023 May 11, 2023	BUY	$0.82 - $1.33 $8,446 - $13,699	10,300 New	10,300 $8,000
Q4 2021 Feb 10, 2022	SELL	$4.38 - $15.67 $100,849 - $360,801	-23,025 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.36 - $8.51 $146,439 - $195,942	23,025 New	23,025 $163,000

128

79.5M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $158M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.